LB Pharmaceuticals Inc (LBRX) insider trading

Every open-market stock purchase and sale by LB Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Deep Track Biotechnology Master Fund Ltd. (Insider) bought $10M in the last 90 days, growing their stake 76%.

Last 12 months: insiders bought $20M (2 buys) and sold $0 (0 sales). Last close $39.42 on Oct 22, 2026.

Recent LBRX insider trades

DateInsiderTradeValue
Oct 9, 2026Susan Gani Kozauer (C-suite exec)Bought (not open market)—
Oct 9, 2026Joseph M Miller (CFO)Bought (not open market)—
Jul 30, 2026Deep Track Biotechnology Master Fund Ltd. (Insider)Bought$10M
Jun 3, 2026William P Kane Jr (Insider)Bought (not open market)—
Jun 3, 2026Rekha Hemrajani (Insider)Bought (not open market)—
Jun 3, 2026Ran Nussbaum (Insider)Bought (not open market)—
Jun 3, 2026J. Scott Garland (Insider)Bought (not open market)—
Jun 3, 2026Robert R Ruffolo (Insider)Bought (not open market)—
Jun 3, 2026Rebecca Luse (Insider)Bought (not open market)—
Jun 3, 2026Robert A. Lenz (Insider)Bought (not open market)—
Mar 6, 2026Robert A. Lenz (Insider)Bought (not open market)—
Feb 6, 2026Deep Track Biotechnology Master Fund Ltd. (Insider)Bought$8M
Feb 6, 2026Deep Track Biotechnology Master Fund Ltd. (Insider)Bought$2M
Dec 10, 2025Panandiker Kaya Kamlesh Pai (C-suite exec)Bought (not open market)—

Who's trading LBRX

Get free alerts when an insider at LB Pharmaceuticals Inc files a new trade →